LCAM
AMGN icon

London & Capital Asset Management’s Amgen AMGN Stock Holding History

London & Capital Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$252K Sell
717
-546
-43% -$195K ﹤0.01% 207
2025
Q4 		$413K Buy
+1,263
New +$401K ﹤0.01% 182
2025
Q1 		– Sell
-11,184
Closed -$2.91M – 97
2024
Q4 		$2.91M Sell
11,184
-110,951
-91% -$32.9M 0.25% 56
2024
Q3 		$39.4M Sell
122,135
-599
-0.5% -$196K 3.12% 6
2024
Q2 		$38.3M Sell
122,734
-27,117
-18% -$7.97M 3.24% 5
2024
Q1 		$42.6M Sell
149,851
-732
-0.5% -$214K 3.25% 8
2023
Q4 		$43.4M Sell
150,583
-8,551
-5% -$2.33M 3.64% 3
2023
Q3 		$42.8M Buy
159,134
+24,344
+18% +$6.08M 3.91% 3
2023
Q2 		$29.9M Sell
134,790
-11,143
-8% -$2.59M 2.96% 13
2023
Q1 		$35.3M Sell
145,933
-5,506
-4% -$1.35M 3.32% 8
2022
Q4 		$39.8M Sell
151,439
-15,275
-9% -$4.09M 3.67% 7
2022
Q3 		$37.6M Sell
166,714
-71
-0% -$17.2K 3.51% 6
2022
Q2 		$40.6M Buy
166,785
+3,090
+2% +$757K 3.22% 6
2022
Q1 		$39.6M Sell
163,695
-8,759
-5% -$2.01M 2.92% 12
2021
Q4 		$38.8M Buy
172,454
+28,124
+19% +$5.94M 2.38% 16
2021
Q3 		$30.7M Buy
+144,330
New +$33.2M 2.23% 18
2021
Q2 		– Sell
-111,994
Closed -$27.9M – 83
2021
Q1 		$27.9M Buy
111,994
+3,144
+3% +$750K 2.6% 10
2020
Q4 		$25M Buy
108,850
+8,875
+9% +$2.05M 2.78% 12
2020
Q3 		$25.4M Sell
99,975
-1,404
-1% -$348K 3.4% 7
2020
Q2 		$23.9M Sell
101,379
-11,505
-10% -$2.62M 4.16% 7
2020
Q1 		$22.9M Buy
112,884
+16,108
+17% +$3.52M 5.38% 7
2019
Q4 		$23.3M Buy
96,776
+91,497
+1,733% +$20.2M 3.75% 11
2019
Q3 		$1.02M Sell
5,279
-37
-0.7% -$7.1K 0.17% 48
2019
Q2 		$980K Sell
5,316
-475
-8% -$85.1K 0.21% 47
2019
Q1 		$1.1M Sell
5,791
-920
-14% -$176K 0.17% 44
2018
Q4 		$1.31M Buy
+6,711
New +$1.31M 0.2% 44

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

London & Capital Asset Management's AMGN Position: Q1 2026 in Review

London & Capital Asset Management reduced its Amgen (AMGN) stake by 43% in Q1 2026, selling an estimated $195K and leaving 717 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #207.

London & Capital Asset Management first reported a position in AMGN in Q4 2018 and has held it in 26 quarters since. The position peaked at $43.4M in Q4 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • London & Capital Asset Management held 717 shares of Amgen worth $252K as of Q1 2026.
  • London & Capital Asset Management sold 546 Amgen shares in Q1 2026, an estimated $195K.
  • Amgen made up ﹤0.01% of London & Capital Asset Management's portfolio in Q1 2026, its #207 holding.
  • London & Capital Asset Management first reported a position in Amgen in Q4 2018 and has held it in 26 quarters since.
  • London & Capital Asset Management's Amgen position peaked at $43.4M in Q4 2023.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on London & Capital Asset Management's 13F filing for Q1 2026, filed 15 May 2026.